AP2008004389A0 - Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine - Google Patents

Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine

Info

Publication number
AP2008004389A0
AP2008004389A0 AP2008004389A AP2008004389A AP2008004389A0 AP 2008004389 A0 AP2008004389 A0 AP 2008004389A0 AP 2008004389 A AP2008004389 A AP 2008004389A AP 2008004389 A AP2008004389 A AP 2008004389A AP 2008004389 A0 AP2008004389 A0 AP 2008004389A0
Authority
AP
ARIPO
Prior art keywords
stavudine
navirapine
pharmaceutical combinations
combinations containing
containing lamivudine
Prior art date
Application number
AP2008004389A
Other languages
English (en)
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Publication of AP2008004389A0 publication Critical patent/AP2008004389A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AP2008004389A 2005-08-31 2006-08-31 Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine AP2008004389A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1057MU2005 2005-08-31
PCT/GB2006/003229 WO2007026156A1 (fr) 2005-08-31 2006-08-31 Combinaisons pharmaceutiques contenant de la lamivudine, de la stavudine et de la névirapine

Publications (1)

Publication Number Publication Date
AP2008004389A0 true AP2008004389A0 (en) 2008-04-30

Family

ID=37442043

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2008004389A AP2008004389A0 (en) 2005-08-31 2006-08-31 Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine

Country Status (14)

Country Link
US (1) US20080241265A1 (fr)
EP (1) EP1931358B1 (fr)
KR (1) KR20080053317A (fr)
AP (1) AP2008004389A0 (fr)
AT (1) ATE484284T1 (fr)
AU (1) AU2006286314A1 (fr)
BR (1) BRPI0617074A2 (fr)
CA (1) CA2620853A1 (fr)
DE (1) DE602006017569D1 (fr)
ES (1) ES2352216T3 (fr)
MA (1) MA29813B1 (fr)
NZ (1) NZ566796A (fr)
WO (1) WO2007026156A1 (fr)
ZA (1) ZA200802751B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104203244A (zh) * 2012-03-05 2014-12-10 希普拉有限公司 包含拉米夫定、festinnvir和奈韦拉平的抗反转录病毒药物组合物
CN104677786B (zh) * 2015-03-09 2017-07-18 上海理工大学 一种基于双目3d视觉的休止角测量方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
US5616578A (en) * 1993-08-26 1997-04-01 The Dupont Merck Pharmaceutical Company Method of treating human immunodeficiency virus infection using a cyclic protease inhibitor in combination with a reverse transcriptase inhibitor
ATE326971T1 (de) * 1997-08-25 2006-06-15 Boehringer Ingelheim Pharma Pharmazeutische suspension mit nevirapine hemihydrat
KR100566445B1 (ko) * 1998-01-16 2006-03-31 메디비르 아베 항바이러스제
PL366089A1 (en) * 2000-03-30 2005-01-24 Bristol-Myers Squibb Company Sustained release beadlets containing stavudine
IT1318463B1 (it) * 2000-04-12 2003-08-25 Archimica S P A Ora Clariant L Procedimento per la preparazione di 5'-acetilstavudina.

Also Published As

Publication number Publication date
EP1931358B1 (fr) 2010-10-13
BRPI0617074A2 (pt) 2011-07-12
MA29813B1 (fr) 2008-09-01
DE602006017569D1 (de) 2010-11-25
CA2620853A1 (fr) 2007-03-08
EP1931358A1 (fr) 2008-06-18
ES2352216T3 (es) 2011-02-16
ATE484284T1 (de) 2010-10-15
KR20080053317A (ko) 2008-06-12
NZ566796A (en) 2011-04-29
ZA200802751B (en) 2009-07-29
US20080241265A1 (en) 2008-10-02
AU2006286314A1 (en) 2007-03-08
WO2007026156A1 (fr) 2007-03-08

Similar Documents

Publication Publication Date Title
IL190563A0 (en) Additional content information
GB0507711D0 (en) Improved blister piercing
PL385565A1 (pl) Folie, wytwarzane z nich opakowania oraz sposoby stosowania
AP2008004533A0 (en) Pharmaceutical combination
GB2427290A8 (en) Common descriptor format
EP1849270A4 (fr) Interfonctionnement
IL190830A0 (en) Stable pharmaceutical formulaions containing escitalopram and bupropion
ZA200804666B (en) Pharmaceutical combination
IL186135A0 (en) Eg1117 and eg307 polynucleotides and uses thereof
GB2436210B (en) Stationery
AP2008004389A0 (en) Pharmaceutical combinations containing lamivudine,stavudine,stavudine and navirapine
EP1949264A4 (fr) Interfonctionnement d'applications
GB0522113D0 (en) vWFA-domain containing proteins
AU300062S (en) Pen
GB0506249D0 (en) Pharses and word
AU306916S (en) Stopper
AU306017S (en) Stopper
AU306018S (en) Stopper
GB0500691D0 (en) Pharmaceutical combinations
GB0510166D0 (en) Envelope
GB0502311D0 (en) Scratchback envelope
GB0515007D0 (en) Popper stopper
GB0500826D0 (en) Pharmaceutical use
IL189812A0 (en) Eg8798 and eg9703 polynucleotides and uses thereof
GB0519195D0 (en) Multi pocket disc-holder